Detection Cutoff Levels for Common Drugs and Alcohol in Hair Follicle Screening

While hair testing provides valuable insights into drug use, categorising individuals into low, medium, and high usage groups based solely on hair analysis has several limitations:

1. Biological Variability

• Hair Growth Rates: Differences in hair growth rates among individuals can affect the concentration of drugs in the hair. Faster-growing hair may dilute drug concentrations, while slower growth can lead to higher concentrations over the same period.

• Hair Type and Colour: Drug incorporation into hair can vary based on its texture, porosity, and melanin content. For instance, darker or more porous hair tends to absorb more drugs, potentially skewing results.

2. Environmental Contamination

• Passive Exposure: Incidental exposure to drugs (e.g., secondhand smoke, contamination from handling drugs) can result in detectable levels in hair without actual ingestion. This may falsely categorise someone as a “low” or “medium” user.

• External Contaminants: Drugs or metabolites may adhere to the hair externally, particularly in environments where drugs are present, further complicating categorisation.

3. Inconsistent Drug Incorporation

• Drug-Specific Differences: Some drugs are more readily incorporated into hair than others. For example, highly lipophilic drugs like THC may accumulate more easily than hydrophilic drugs, creating inconsistencies in categorising users across drug types.

• Metabolism Variations: Individual metabolic rates affect how quickly drugs and their metabolites are processed, impacting the concentrations deposited in hair.

4. Limitations of Testing Sensitivity

• Cutoff Levels: Laboratories use specific cutoff levels to report positive results. If these levels are set too high, infrequent or low-level users may be categorised incorrectly as “non-users” or “low” users.

• Detection Limits: Hair testing may not detect extremely low-level use or distinguish between “low” and “medium” usage with precision, particularly for substances used sporadically.

5. Timeline Ambiguity

• Segmented Analysis Required: Without segmenting the hair, a single test may represent an average drug use over months, obscuring periods of heavy or light use.

• Overlapping Periods: Categorisation may not account for variations in drug use patterns over time (e.g., a chronic user who recently reduced consumption might still be classified as “high”).

6. Polydrug Use

• Confounding Effects: Users of multiple drugs may have complex usage patterns that do not align neatly with a single categorisation. One drug may appear at a “high” level while another shows “low,” making overall classification difficult.

7. Lack of Contextual Information

• Intentional vs. Unintentional Use: Hair analysis cannot distinguish between intentional drug use, medical prescriptions, or accidental ingestion.

• Frequency vs. Quantity: Hair testing measures drug deposition but does not directly reflect how frequently or in what quantities the drug was consumed.

8. Legal and Ethical Concerns

• Stigmatisation: Categorising individuals into simplistic groups could lead to unfair assumptions about their behaviour, especially in legal or employment contexts.

• Judicial Scrutiny: Courts or regulatory bodies may question the validity of categorising users based solely on hair testing, given its inherent variability and limitations.